FDA Hormone Therapy Outreach Will Stress Short-Term, Low-Dose Use

FDA's hormone therapy outreach campaign will initially focus on encouraging short-term, low-dose use, Commissioner McClellan told the House Agriculture Appropriations Subcommittee March 6